top
Search terms
Results 1 - 6 of 6 - ordered by :
Escardio

Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention lengthens survival in patients at high risk of death after ST-segment elevation myocardial infarction ...

Date : 03/09/2019
Escardio

Genotype-guided oral P2Y12 inhibition reduces bleeding without raising clotting risk in heart attack patients undergoing stent implantation, according to late breaking results from the POPular ...

Date : 03/09/2019
Escardio

While the investigator-initiated study showed that DAPT (a combination of aspirin and the P2Y12-receptor blocker clopidogrel) does not decrease the rate of major adverse cardiovascular and ...

Date : 31/08/2015
Escardio

EMBARGO : 31 August 2015 at 14:15 BST The ATLANTIC2 study showed that the potent P2Y12 antagonist ticagrelor given in the ambulance (pre-hospital) in patients with ST-segment elevation myocardial ...

Date : 31/08/2015
Escardio

[...]results from the WOEST study (What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing) show that a strategy of adding clopidogrel ...

Date : 28/08/2012
Escardio

[...]the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY) also found a consistently greater risk of haemorrhage in the 24-month dual therapy ...

Date : 30/08/2011